What are the best cannabis-focused private equity firms?

The cannabis private equity and venture capital landscape features a mix of dedicated specialists navigating the sector's complex regulatory environment. Rather than touching the plant directly (due to federal restrictions in the U.S.), many of the most successful firms focus heavily on multistate operators (MSOs), ancillary tech, logistics, and B2B platforms.

The most prominent and active private equity and venture capital firms in the cannabis space include:

• Gotham Green Partners - A prominent New York-based private equity firm founded by Jason Adler. They focus on global cannabis and cannabis-related enterprises, deploying massive capital checks across the supply chain, distressed assets, and restructuring plays.
• Casa Verde Capital - Co-founded by Karan Wadhera and famously backed by Snoop Dogg, this firm focuses primarily on early-stage and high-growth ancillary businesses rather than plant-touching operations. Their portfolio highlights B2B tech giants like LeafLink and Dispense.
• Entourage Effect Capital - Formerly known as Cresco Capital Partners, this private equity firm invests across the entire cannabis ecosystem, including cultivation, processing, distribution, and tech-enabled ancillary services.
• Navy Capital - A fundamental, research-driven firm targeting best-in-class global cannabis businesses across both public and private markets, emphasizing strong governance and operational efficiency.
• Green Acre Capital - A prominent private investment fund based out of Canada that has historically focused on the evolution of the Canadian medical and recreational markets as well as international opportunities.

If you'd like to narrow this down, tell me:

• Are you looking for plant-touching vs. ancillary investment targets?
• Are you looking to raise capital or invest capital?

I can provide a more tailored breakdown based on your goals.

If by “best” you mean most established, cannabis-specialist private-capital firms with meaningful track records, a useful shortlist is:

• meridacap.com — One of the clearest fits for traditional private equity. Merida focuses specifically on cannabis and adjacent infrastructure, and reports 50+ portfolio companies and more than $200M managed across five funds and co-investments (data as of Dec. 31, 2024). Its strategy emphasizes revenue-generating companies rather than very early startups.
• entourageeffect.com — A growth-stage cannabis investment firm founded in 2014. It says it has deployed $140M+ across 60+ portfolio companies and is currently deploying Fund III, with an early-stage allocation through Arcview Ventures Seed Fund.
• poseidonassetmanagement.com — One of the longest-running dedicated cannabis investment platforms, founded in 2013. It invests across company stages and cannabis subsectors rather than concentrating exclusively on buyouts.
• casaverdecapital.com — Founded in 2015 and particularly notable for investments in ancillary cannabis businesses such as technology, infrastructure and services. Casa Verde says it can invest across the financing lifecycle, with an emphasis on scalable, capital-efficient companies.

How I'd distinguish them

One important distinction: not all of these are conventional buyout PE firms. Cannabis-specialist capital is unusually weighted toward venture capital and growth equity because federal illegality, financing constraints, and fragmented state markets have historically made conventional leveraged buyouts more difficult.

If you're looking specifically for firms that will acquire controlling stakes in operating cannabis companies—rather than minority VC/growth investments—I can narrow this to the cannabis PE firms doing $10M–$100M+ control transactions and compare their investment size, geography, preferred subsectors, and recent deals.

Because mainstream institutional private equity (PE) firms have largely stayed on the sidelines due to federal illegality in the United States, specialized boutique private equity and venture capital firms have dominated the cannabis landscape. These firms focus on growth equity, operational restructuring, and distressed debt/equity financing across plant-touching operators and ancillary businesses.

The most prominent and active private equity and growth investment firms in the cannabis sector include:

• Gotham Green Partners — A New York-based private equity firm specializing in global cannabis and cannabis-related enterprises. They are known for deploying massive capital into both plant-touching operations and debt financing structures across the industry.
• Merida Capital Holdings — A data-driven private equity firm targeting fundamental growth drivers in the cannabis and hemp ecosystems. Merida focuses heavily on cultivation technologies, security, analytics, and ancillary products rather than just retail.
• Entourage Effect Capital — Formerly known as Cresco Capital Partners, this private equity firm invests across the entire cannabis supply chain, including cultivation, processing, brands, and distribution.
• Casa Verde Capital — Co-founded by Snoop Dogg, Casa Verde operates primarily as a venture/growth investor focusing on high-growth ancillary cannabis businesses (i.e., companies providing goods and services to the industry without touching the plant itself, such as B2B software, logistics, and tech infrastructure).
• Green Acre Capital — A prominent private investment fund based in Canada that has deployed substantial capital into the legal cannabis industry spanning North America, Latin America, and Europe, targeting retail, brands, and biotech.
• Altitude Investment Management — A global investment firm focused on early-stage and growth-stage cannabis companies, touching both consumer packaged goods (CPG) and tech/infrastructure.

If you'd like to narrow this down, let me know:

• Are you looking to pitch a cannabis business for funding?
• Are you interested in plant-touching operations or ancillary services?
• Do you need insight into debt vs. equity financing trends?

If by “best” you mean the strongest cannabis-specialist private-capital firms by track record, sector expertise, portfolio depth, and institutional sophistication, I’d put the following near the top. One caveat: the cannabis private-capital universe mixes VC, growth equity, private equity, merchant banking, and hybrid strategies, so these aren't all directly comparable.

1. Merida Capital Holdings

My #1 if you specifically mean cannabis-focused private equity.

Merida describes itself as a private-equity firm focused on the fundamental growth drivers of cannabis. Its strategy emphasizes revenue-generating companies, particularly the infrastructure, technology, services and other businesses supporting the cannabis ecosystem. The firm says it has invested in 50+ companies and manages about $200 million across five funds and co-investments.

This is the firm I'd investigate first if you're looking for a conventional institutional PE-style partner rather than a seed VC.

2. Casa Verde Capital

Casa Verde is one of the most established cannabis-specialist investment firms, founded in 2015. It invests across stages but has historically had a particularly strong emphasis on ancillary businesses, technology, consumer brands and scalable businesses rather than businesses directly touching the plant.

Its portfolio includes companies such as Dutchie, LeafLink, Metrc and Vangst, giving it unusually strong cannabis ecosystem connectivity.

Best fit: cannabis software, marketplaces, infrastructure, consumer and ancillary companies.

3. Poseidon Asset Management

Poseidon is another foundational cannabis investment platform. Current industry investment data places it among the most active U.S. cannabis investors, alongside Casa Verde and Phyto Partners.

It's particularly interesting if you want a multi-stage cannabis specialist rather than a narrowly defined buyout fund.

4. Entourage Effect Capital

Entourage Effect is worth considering for growth-stage businesses and companies serving the broader cannabis ecosystem. It has historically operated across early-stage through growth investments and is generally more institutionally oriented than a typical cannabis startup fund.

5. Gotham Green Partners

Gotham Green is more relevant once a company has meaningful revenue, scale and institutional financing requirements. It occupies something of a VC/PE hybrid position, with a focus on later-stage growth and structured capital.

6. Tuatara Capital

Tuatara is particularly interesting if you're evaluating plant-touching businesses, operators, vertical integration or assets where operational execution matters. Its strategy is quite different from Casa Verde's ancillary-heavy approach.

7. Panther Group

Panther is not a traditional PE fund, but it's worth putting on the list because of its breadth. It reports 40+ direct cannabis investments across 25+ subsectors and offers equity, SPVs, secured debt and cannabis real-estate strategies.

My shortlist by situation

• Pure-play cannabis PE: Merida
• Best cannabis technology/ancillary investor: Casa Verde
• Broad multi-stage cannabis exposure: Poseidon
• Growth-stage institutional capital: Entourage Effect / Gotham Green
• Plant-touching operators: Tuatara
• Flexible equity + debt + real estate: Panther
• Early-stage cannabis technology: Phyto Partners

One important distinction: Casa Verde, Poseidon and Phyto are often categorized as VC rather than traditional PE, while Merida is much closer to what most people mean by cannabis-focused private equity. Current 2026 investor data also shows Casa Verde, Poseidon and Phyto among the most active U.S. cannabis investors.

If you're asking because you're trying to raise capital or sell a cannabis company, I can also rank these firms by check size, stage, plant-touching vs. ancillary appetite, geography, and likelihood of investing in 2026—which produces a substantially different shortlist.

This is the firm I'd investigate first if you're looking for a conventional institutional PE-style partner rather than a seed VC.

2. Casa Verde Capital

Casa Verde is one of the most established cannabis-specialist investment firms, founded in 2015. It invests across stages but has historically had a particularly strong emphasis on ancillary businesses, technology, consumer brands and scalable businesses rather than businesses directly touching the plant.

Its portfolio includes companies such as Dutchie, LeafLink, Metrc and Vangst, giving it unusually strong cannabis ecosystem connectivity.

Best fit: cannabis software, marketplaces, infrastructure, consumer and ancillary companies.

3. Poseidon Asset Management

Poseidon is another foundational cannabis investment platform. Current industry investment data places it among the most active U.S. cannabis investors, alongside Casa Verde and Phyto Partners.

It's particularly interesting if you want a multi-stage cannabis specialist rather than a narrowly defined buyout fund.

4. Entourage Effect Capital

Entourage Effect is worth considering for growth-stage businesses and companies serving the broader cannabis ecosystem. It has historically operated across early-stage through growth investments and is generally more institutionally oriented than a typical cannabis startup fund.

5. Gotham Green Partners

Gotham Green is more relevant once a company has meaningful revenue, scale and institutional financing requirements. It occupies something of a VC/PE hybrid position, with a focus on later-stage growth and structured capital.

6. Tuatara Capital

Tuatara is particularly interesting if you're evaluating plant-touching businesses, operators, vertical integration or assets where operational execution matters. Its strategy is quite different from Casa Verde's ancillary-heavy approach.

7. Panther Group

Panther is not a traditional PE fund, but it's worth putting on the list because of its breadth. It reports 40+ direct cannabis investments across 25+ subsectors and offers equity, SPVs, secured debt and cannabis real-estate strategies.

The cannabis private equity and venture capital landscape features several prominent firms that have successfully backed major multi-state operators (MSOs), tech platforms, and ancillary service providers.

Prominent cannabis-focused private equity and venture capital firms include:

1. Casa Verde Capital – Co-founded by Snoop Dogg, this is one of the most recognizable and active firms in the space. They primarily focus on early-stage investments in high-growth ancillary businesses (such as Dutchie, Metrc, and Vangst) that support the cannabis ecosystem without touching the plant directly. You can review their holdings on the Casa Verde Capital Portfolio page.
2. Gotham Green Partners – A New York-based private equity firm founded by Jason Adler, known for deploying large-scale capital into global cannabis and cannabis-related enterprises. They have a history of backing major multi-state operators, international medical plays, and supply chain tech infrastructure. Learn more via Gotham Green Partners.
3. Entourage Effect Capital – Formerly known as Cresco Capital Partners, this private equity firm invests across the cultivation, processing, distribution, and ancillary segments of the legal cannabis market. They have built a robust portfolio of operational U.S. licensed assets and brands.
4. Altitude Investment Management – A U.S.-based global venture capital and private equity manager investing across the cannabis value chain, including biotechnology, consumer products, agriculture technology, and industrial applications.
5. Green Acre Capital – A prominent private investment fund with a strong focus on the Canadian medical and recreational markets, as well as select international opportunities.

Would you like to explore ancillary vs. plant-touching investment strategies , or are you looking for details on a specific firm's minimum investment requirements/fund focus?

If by “best” you mean specialist firms with a meaningful cannabis track record, rather than large generalist PE firms that occasionally invest in cannabis, I’d put these near the top:

1. Merida Capital Holdings — Best pure-play PE fit

• Probably the clearest answer if you're specifically looking for private equity rather than VC.
• Focuses on growth-stage, revenue-generating cannabis businesses and the infrastructure/services surrounding the industry.
• Merida says it has invested in 50+ companies and manages $200M+ across five funds and co-investments (data as of Dec. 31, 2024).
• Particularly interesting for cultivation technology, ancillary businesses, medical cannabis, consumer products and other picks-and-shovels businesses.

2. Gotham Green Partners — Best for larger growth-stage opportunities

• Cannabis-focused investor using a mix of growth equity, private equity and structured/mezzanine capital.
• Has historically invested across essentially the full cannabis value chain.
• A strong candidate for established companies needing substantial growth capital rather than a small seed round.

3. Entourage Effect Capital — Strong institutional cannabis specialist

• Formerly Cresco Capital Partners.
• Focuses on companies positioned to scale as cannabis markets mature and federal restrictions evolve.
• Its portfolio has included operators such as Curio Wellness and Organic Remedies.

4. Casa Verde Capital — Best cannabis ecosystem/ancillary investor

• One of the earliest dedicated cannabis investment firms, founded in 2015.
• Invests across financing stages, with an emphasis on scalable, capital-efficient businesses.
• Particularly notable for cannabis software, technology, marketplaces and other ancillary businesses rather than simply buying cultivation/retail operators.
• Its portfolio has included LeafLink and Dutchie, among others.

5. Poseidon Asset Management — Best long-standing specialist

• Founded in 2013 and among the longest-running dedicated cannabis investment managers.
• Invests across company stages and subsectors and emphasizes hands-on involvement with portfolio companies.
• More VC/growth-investment oriented than traditional buyout PE, so I'd rank it slightly differently depending on your definition of PE.

6. Phyto Partners — Strong technology/ancillary option

• Cannabis-focused fund providing debt and equity capital to privately held companies.
• Particularly relevant for cannabis technology, infrastructure and services.

My shortlist by strategy

One important distinction: “cannabis-focused” doesn't necessarily mean “buyout PE.” A lot of the prominent names in the sector are actually VC, growth equity, private credit, or hybrid funds. For example, current industry databases classify Casa Verde and Poseidon primarily as VC funds, while Merida explicitly describes itself as a private-equity firm.

If you're looking to raise capital for a cannabis company, I can also rank these firms by typical check size, stage, sector focus, geography, notable portfolio companies, and likelihood of investing in plant-touching vs. ancillary businesses.

The cannabis private equity and venture capital landscape features a mix of dedicated specialists funding plant-touching operators, ancillary tech, logistics, and consumer brands.

The prominent and most active firms specializing in the cannabis sector include:

• Casa Verde Capital : Headquartered in Los Angeles, this is one of the most recognizable venture and growth equity firms in the space (co-founded by Snoop Dogg). They primarily focus on high-growth ancillary businesses spanning B2B platforms, financial services, compliance, and technology rather than direct plant-touching cultivation.
• Gotham Green Partners : A New York-based private equity firm founded by Jason Adler. They deploy substantial capital globally across the entire cannabis value chain, participating in major debt and equity financings for multi-state operators (MSOs), international licensees, and infrastructural businesses.
• Entourage Effect Capital : Formerly known as Cresco Capital Partners, this private equity firm invests across the entire lifecycle of legal cannabis businesses—targeting cultivators, processors, brands, and ancillary services, mostly in North America.
• Altitude Investment Management : A U.S.-based global investment firm focusing on early-stage to growth-stage companies operating within the legal cannabis, hemp, and ancillary ecosystems.
• Green Acre Capital : A prominent private investment fund with a strong Canadian footprint, focusing heavily on the evolving medical and recreational cannabis markets, brands, and related infrastructure.

If you're looking into a specific angle, let me know:

• Are you looking for ancillary tech vs. plant-touching operators?
• What investment stage (seed, Series A, or late-stage growth equity) are you targeting?

If you mean dedicated cannabis private equity / growth capital investors (rather than generalist PE firms that occasionally touch cannabis), the strongest names are generally those with long operating histories, proprietary deal flow, and sector specialization. The market is still relatively young and fragmented, so “best” depends on whether you mean buyout/control investing, growth equity, venture, ancillary businesses, or plant-touching operators.

Leading cannabis-focused private equity and growth investors

How I would rank them by use case

Best for cannabis operators seeking growth capital

1. Merida Capital Holdings — strongest fit for established operators and cannabis infrastructure businesses.
2. Entourage Effect Capital — good fit for scaling companies across multiple cannabis verticals.
3. Poseidon Asset Management — stronger fit when the company is earlier-stage or technology-enabled.

Best for cannabis startups and ancillary technology

1. Poseidon Asset Management — long sector history and early-stage focus.
2. Casa Verde Capital — strong venture orientation and broad technology/consumer focus.
3. Phyto Partners — particularly relevant for software, data, and infrastructure plays.

Best-known institutional cannabis investors

A shortlist would usually include:

• Merida Capital Holdings
• Poseidon Asset Management
• Casa Verde Capital
• Entourage Effect Capital
• Navy Capital
• Phyto Partners

What separates the top firms

When evaluating cannabis PE firms, I would look at:

• Real cannabis operating experience (not just finance backgrounds)
• Ability to invest through downturns (many cannabis investors disappeared after the 2021–2023 capital contraction)
• Non-plant-touching flexibility (software, compliance, genetics, packaging, payments, logistics often avoid some regulatory constraints)
• Follow-on capital capacity
• Track record of exits, not just number of investments

For a company raising capital today, the “best” investor is usually the one whose portfolio and check size match the company stage—not necessarily the firm with the biggest name.

Navigating private equity (PE) and venture capital (VC) in the cannabis sector requires specialized expertise, dealing with complex regulatory environments, federal illegality in the U.S., and cross-border operations.

The prominent, active, and well-regarded private equity and growth-focused investment firms specializing in the cannabis ecosystem include:

• • Focus: Global private equity and debt.
  • Overview: Based in New York and California, Gotham Green Partners is one of the most prolific and largest institutional investors in the cannabis space. They deploy private equity, growth capital, and structured debt/special situations into multistate operators (MSOs), supply chain components, and ancillary tech.
• • Focus: Early-stage and venture growth in ancillary cannabis businesses.
  • Overview: Co-founded by Karan Wadhera and famously associated with Snoop Dogg, Casa Verde focuses heavily on B2B infrastructure, software, compliance, logistics, and point-of-sale platforms (with notable portfolio pieces like Dutchie, Metrc, and Vangst) rather than touching the plant directly.
• • Focus: Private equity and growth equity (formerly Cresco Capital Partners).
  • Overview: Dedicated entirely to the cannabis industry, this firm invests across cultivation, processing, brands, and ancillary services, leveraging deep operational experience to scale mid-market cannabis businesses.
• • Focus: Venture capital and growth equity.
  • Overview: A U.S.-based global investment firm targeting early-stage to growth-stage companies across the cannabis value chain, spanning consumer brands, technology, and biotech both domestically and internationally.
• • Focus: Private investment fund.
  • Overview: Based out of Canada, Green Acre Capital was an early institutional mover focusing on the evolving medical and recreational landscape, backing licensed producers, retail, and tech infrastructure.

If you are looking to approach these firms or analyze a specific sub-sector, let me know:

• Are you interested in plant-touching operations (MSOs) or ancillary tech/services?
• Are you looking for venture capital funding or late-stage private equity?

If you mean institutional private-capital firms that specialize in cannabis, rather than generalist PE firms that occasionally invest in the sector, I’d put the following near the top of the list as of 2026:

1. Merida Capital Holdings

meridacap.com is probably the clearest answer if you're specifically looking for a cannabis-focused private equity firm.

Merida says it has invested in 50+ companies and manages about $200 million across five funds and co-investments. Its strategy emphasizes revenue-generating companies and infrastructure/services around cultivation, medical cannabis, pharmaceuticals and consumer products.

Particularly attractive for: cannabis ancillary businesses, technology, cultivation infrastructure, biotech/medical, and established growth companies.

2. Entourage Effect Capital

entourageeffect.com is one of the longest-running dedicated cannabis investment platforms. It was founded in 2014 as Cresco Capital Partners and says it has deployed $140M+ across 60+ portfolio companies and is currently deploying Fund III.

It's especially interesting if you're a growth-stage cannabis company approaching institutional scale.

3. Rose Capital

rosecapital.com takes a somewhat different approach, emphasizing strategic capital and operating partnerships. Its stated focus is data & analytics, distribution/logistics, and CPG/ancillary products.

I'd look closely at Rose if you're building an ancillary or consumer-facing cannabis business rather than simply seeking capital for cultivation/retail.

4. FocusGrowth Asset Management

focusgrowth.com is particularly notable because it operates across the capital structure rather than behaving like a traditional buyout fund. It reports $1.1 billion deployed into cannabis since 2020, predominantly through senior-secured credit, as of Q1 2026.

That makes it potentially much more relevant for a profitable MSO/operator seeking growth capital, refinancing or a structured transaction than for an early-stage startup.

5. Chicago Atlantic

chicagoatlantic.com is another heavyweight, but it's more accurately described as private credit than traditional PE. It specializes in highly secured financing to U.S. state-licensed cannabis operators and has a dedicated cannabis-focused credit strategy.

If you're evaluating firms from the perspective of raising $10M–$100M+ for an operating cannabis business, Chicago Atlantic belongs on the shortlist even though it's technically a lender rather than conventional PE.

6. Poseidon Asset Management

Poseidon is more VC/growth oriented than classic buyout PE. Current industry databases show a substantial cannabis investment history, with investments spanning cannabis software, SaaS and other ancillary businesses.

It's more appropriate for early/growth-stage companies than for a mature operator looking for a leveraged buyout.

7. Aquinnah Capital Partners

aquinnahcapital.com is worth watching for structured/private capital. It describes its strategy as providing institutional-grade capital to U.S. cannabis operators through structures combining downside protection with equity upside.

That's particularly interesting in cannabis because conventional bank financing remains constrained.

My shortlist by situation

• Buying/investing in cannabis companies: Merida, Entourage Effect, Rose
• Raising growth equity: Merida, Entourage Effect
• Early-stage cannabis/ancillary startup: Poseidon
• Large established operator needing debt: Chicago Atlantic, FocusGrowth
• Structured equity/debt: Aquinnah, FocusGrowth
• Ancillary cannabis business: Merida, Rose, Entourage Effect
• Pure-play cannabis PE exposure: Merida is probably the first firm I'd investigate.

One important distinction: “cannabis private equity” is a surprisingly broad label. Some firms called PE investors are actually VC funds, private-credit managers, or hybrid capital providers. A current industry database lists 43 cannabis-focused PE investors, while broader cannabis-investor databases contain hundreds of investors.

If you're asking because you want to raise capital or sell a cannabis company, tell me the approximate revenue/EBITDA, state(s), business type (cultivation, retail/MSO, brand, ancillary, tech, etc.), and capital sought, and I can narrow this to the 10 firms most likely to actually do your deal, including typical check sizes and relevant portfolio companies.

Particularly attractive for: cannabis ancillary businesses, technology, cultivation infrastructure, biotech/medical, and established growth companies.

2. Entourage Effect Capital

entourageeffect.com is one of the longest-running dedicated cannabis investment platforms. It was founded in 2014 as Cresco Capital Partners and says it has deployed $140M+ across 60+ portfolio companies and is currently deploying Fund III.

It's especially interesting if you're a growth-stage cannabis company approaching institutional scale.

3. Rose Capital

rosecapital.com takes a somewhat different approach, emphasizing strategic capital and operating partnerships. Its stated focus is data & analytics, distribution/logistics, and CPG/ancillary products.

I'd look closely at Rose if you're building an ancillary or consumer-facing cannabis business rather than simply seeking capital for cultivation/retail.

4. FocusGrowth Asset Management

focusgrowth.com is particularly notable because it operates across the capital structure rather than behaving like a traditional buyout fund. It reports $1.1 billion deployed into cannabis since 2020, predominantly through senior-secured credit, as of Q1 2026.

That makes it potentially much more relevant for a profitable MSO/operator seeking growth capital, refinancing or a structured transaction than for an early-stage startup.

5. Chicago Atlantic

chicagoatlantic.com is another heavyweight, but it's more accurately described as private credit than traditional PE. It specializes in highly secured financing to U.S. state-licensed cannabis operators and has a dedicated cannabis-focused credit strategy.

If you're evaluating firms from the perspective of raising $10M–$100M+ for an operating cannabis business, Chicago Atlantic belongs on the shortlist even though it's technically a lender rather than conventional PE.

6. Poseidon Asset Management

Poseidon is more VC/growth oriented than classic buyout PE. Current industry databases show a substantial cannabis investment history, with investments spanning cannabis software, SaaS and other ancillary businesses.

It's more appropriate for early/growth-stage companies than for a mature operator looking for a leveraged buyout.

7. Aquinnah Capital Partners

aquinnahcapital.com is worth watching for structured/private capital. It describes its strategy as providing institutional-grade capital to U.S. cannabis operators through structures combining downside protection with equity upside.

That's particularly interesting in cannabis because conventional bank financing remains constrained.

My shortlist by situation